Navigation Links
Cord Blood Registry Named Bioscience Company of the Year
Date:10/30/2012

SAN BRUNO, Calif., Oct. 30, 2012 /PRNewswire/ -- Cord Blood Registry® (CBR®), the world's largest newborn stem cell bank was named 2012 Bioscience Company of the Year by AZBio, a not-for-profit trade association supporting the growth of Arizona's bioscience industry. CBR was selected by an independent panel of judges made up of leaders from Arizona's bioscience community who reviewed nominations from a broad selection of companies from across the state, and claimed the prize at the AZBio Awards at the Phoenix Convention Center on October 23rd.

(Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO)

"The Bioscience Company of the Year award honors the for-profit bioscience company whose Arizona-based operations did the most to transform the world during the last 12 months," said Joan Koerber-Walker, president and CEO at AZBio. "CBR is a shining example of the innovative work that is driven from right here in Arizona and benefits families around the world. The CBR team delivers services offering the latest in today's technology while providing a foundation for new innovations and cures that will be even more prevalent in the future."

"We are honored that AZBio recognizes our efforts to advance regenerative medicine and change lives through the power of newborn stem cells. Everyone at CBR has worked hard to make this company the largest and most advanced newborn stem cell bank in the world. With leadership comes the responsibility to advance medicine," said Geoffrey Crouse, president and CEO of Cord Blood Registry. "We partner with leading medical researchers to establish clinical trials using CBR processed stem cells as therapies for conditions that have no known cure."

Since its founding, CBR has led the industry in advanced techniques to collect, process and store newborn stem cells for use in transplant medicine and clinical trials.

"We are honored to receive this award from AZBio," said Kristen Swingle, vice president of lab operations at Cord Blood Registry. "Our relentless focus on quality has been recognized by our peers and that makes this even more special."

Advancing Stem Cell Science
CBR is leading the industry in investigating newborn stem cells for regenerative medicine applications by establishing clinical trials with leading medical institutions and researchers across the country.  By pairing researchers with children who have been diagnosed with chronic conditions like autism, cerebral palsy or traumatic brain injury, CBR is providing client families exclusive access to clinical trials to evaluate the efficacy of newborn stem cells in various conditions.

"As the leader and innovator in family banking, we believe every newborn deserves a healthy future and that we have a responsibility to lead the way," said Heather Brown, vice president of scientific & medical affairs at CBR. "This award recognizes that CBR is leading the way in regenerative medicine. We are the only family bank pioneering ground breaking clinical trials evaluating new therapeutic uses of newborn stem cells for unexpected injuries and conditions with no current cure."

About AZBio
AZBio, The Arizona Bioindustry Association, is committed to supporting the growth of Arizona's bioindustry and works with companies who are leading innovators in the fields of health, bio-energy and agriculture.  AZBio represents over 200 corporations, institutes, universities, and biosciecne centers across the State of Arizona and works closely with its national partners, BIO, PhRMA, and AdvaMed to create an environment where life science companies can thrive.

About Cord Blood Registry 
 Cord Blood Registry® (CBR®) is the world's largest and most experienced newborn stem cell bank, safeguarding the newborn stem cells of more than 400,000 children. The company has consistently led the industry in developing technical innovations and establishing FDA-regulated clinical trials.  CBR was the first family bank accredited by AABB and the company's quality standards have been recognized through ISO 9001:2008 certification—the global business standard for quality. CBR has also released more client cord blood units for specific therapeutic use than any other family cord blood bank.  Our research and development efforts are focused on helping the world's leading clinical researchers advance regenerative medical therapies.  For more information, visit www.cordblood.com.


'/>"/>
SOURCE Cord Blood Registry (CBR)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Professor Releases Weight Management and Healthy Blood Sugar Control Products
2. Onconome Announces Results Of Blood Test For Colorectal Cancer; Further Trials Underway
3. New Study in The Journal of Maternal-Fetal and Neonatal Medicine Shows Fetal Cell-Free DNA in Maternal Blood Unaffected by Trisomy Risk
4. IntelliCell BioSciences Files Patent Application for a New Mechanical Method to Separate Stromal Vascular Fraction from the Blood Vessels in Adipose Tissue
5. Long-Term Use of Blood Pressure Medications that Promote Sun Sensitivity May Increase Risk of Lip Cancer in Non-Hispanic Whites
6. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
7. MinuteClinic Joins with American Heart Association to Help Americans Reduce High Blood Pressure
8. Gentris Corporation Announces Collaboration to Study Blood Stability
9. New Study Reveals Wide Variation in Blood Transfusion Practices During Surgery
10. New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
11. Global Growth Factors (Blood And Tissue) Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Europe 2016 Edition: The New Global Agenda " report ... OTC Distribution in Europe - the ... and tracks change. It identifies the driving factors coming into ... consumer healthcare industry now and in the future. It provides ...
(Date:6/23/2016)... 2016 The global chronic ... of combination therapies trend is expected to boost ... CLL were available only in the form of ... in combination with prednisone, and a combination of ... trend of developing combination therapies to treat CLL ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Randall Markarian, DDS, are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s ... 15-16 at the Gateway Convention Center in Collinsville. , They expect ...
Breaking Medicine News(10 mins):